BT200 in Hereditary Bleeding Disorders

Exclusion Criteria

• •1. Clinically significant medical history or ongoing chronic illness that would jeopardize the safety of the patient or compromise the quality of the data derived from his/her participation in this study
• •2. Medical History of spontaneous (not FVIII or FEIBA-associated) venous or arterial thromboembolic events
• •3. History of significant drug allergy or anaphylactic reactions
• •4. Substance abuse, mental illness, or any reason that makes it unlikely in the judgment of the Investigator for the patient to be able to comply fully with study procedures
• •5. Use of medication during 2 weeks before the start of the study, which in the judgment of the Investigator may adversely affect the patient's welfare or the integrity of the study's results
• •6. Concurrent treatment with other experimental drugs or participation in another clinical trial with any investigational drug within 30 days or 5 elimination half-lives (whichever is longer) prior to treatment start -